Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1-like 3 pseudogene (ENSG00000229110, LOC100421387) is a nonfunctional DNA segment sharing strong sequence similarity with the functional heterogeneous nuclear ribonucleoprotein A1 gene. Like other pseudogenes, it lacks key regulatory features or contains disabling mutations that prevent expression of a functional protein product[2][3]. Pseudogenes may occasionally be transcribed into non-coding RNAs or play indirect roles in gene regulation, such as acting as microRNA decoys or affecting RNA interference pathways, but these functions are rare and not established for this particular gene[5]. It is not considered a classical drug target and has no known therapeutic relevance. In summary, this entity is best classified as a pseudogene, not a functional receptor, and should not be considered a therapeutic target for drug development or pharmacological intervention[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1-like 3 pseudogene.